Dr. Reddy's Recalls Citalopram Tablets Due to Chemical Odor Complaints
Dr. Reddy's is recalling 86,093 bottles of Citalopram tablets due to reports of a strong garlic or chemical smell.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a chemical odor complaint without reported injuries or illnesses, fitting the criteria for a moderate severity precautionary recall.
Plain-English summary
Dr. Reddy's Laboratories, Inc. is recalling 86,093 bottles of Citalopram tablets USP, 20mg, 30-count. The affected product is prescription-only and was distributed nationwide. The specific lot number is C201922 with an expiration date of 1/14.
The recall was initiated due to complaints reporting a strong garlic odor or strong chemical smell in the product. This is classified as a Class II recall by the FDA.
Consumers should check their medication for the specific lot number and expiration date listed above. If the product matches the recalled lot, patients should stop using it and contact their healthcare provider or pharmacist for guidance on replacement or further instructions.
The recalled product
- Product
- Citalopram tablets USP, 20mg, 30-count bottle, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupalli, India 502 325, NDC 55111-343-30
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Category
- Drug — Prescription Medication
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: C201922
- Exp 1/14
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 3 recalled by Dr. Reddy's Laboratories, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Dr. Reddy's Laboratories, Inc.
See all →- ModerateVarenicline tablets recalled after an assay value fell below specification
FDA (Drugs) · 2025-12-17
- Moderate
- HighOmeprazole capsule bottle contained a foreign divalproex sodium tablet
FDA (Drugs) · 2025-07-23
- SevereLevetiracetam Injection Label Mismatch Nationwide Recall
FDA (Drugs) · 2025-04-23
- ModerateFDA Recalls JAVYGTOR Tablets Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2024-12-18